Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Omega-3 (EPA/DHA) | Phosphatidylserine | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 2-4g combined EPA/DHA daily (targeting 2:1 EPA:DHA ratio for inflammation; 1:1 for cognitive) | 100-300mg daily |
| Timing | With meals containing fat for absorption. Split dose AM/PM. | With meals (fat-containing preferred for absorption). Can be taken morning or evening. Cortisol-blunting effects are relevant for evening/pre-bed dosing in stressed individuals. |
| Cycle Duration | ongoing | Ongoing; no cycling required. Clinical benefits observed from 6-12 weeks. |
| Evidence Level | strong_human | strong_human |
EPA and DHA incorporate into cell membrane phospholipids, modulating membrane fluidity and lipid raft signaling. EPA competitively inhibits arachidonic acid conversion via COX-2 and 5-LOX, reducing pro-inflammatory eicosanoids (PGE2, LTB4) while generating anti-inflammatory resolvins and protectins. DHA is critical for neuronal membrane integrity, modulating BDNF expression and synaptic plasticity via Nrf2 and NF-kB pathways.
2-4g combined EPA/DHA daily (targeting 2:1 EPA:DHA ratio for inflammation; 1:1 for cognitive)
With meals containing fat for absorption. Split dose AM/PM.
ongoing
Major phospholipid component of neuronal cell membranes (15-20% of total phospholipid pool) that maintains membrane fluidity and supports signal transduction. Serves as a cofactor for protein kinase C (PKC), Na+/K+-ATPase, and other membrane-bound enzymes critical for neurotransmitter release. Blunts HPA axis hyperactivation by modulating corticotrophin-releasing factor (CRF) receptor interactions, attenuating cortisol release during physical and psychological stress. Facilitates acetylcholine, dopamine, and norepinephrine release, and enhances glucose metabolism in the brain.
100-300mg daily
With meals (fat-containing preferred for absorption). Can be taken morning or evening. Cortisol-blunting effects are relevant for evening/pre-bed dosing in stressed individuals.
Ongoing; no cycling required. Clinical benefits observed from 6-12 weeks.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →